CSIMarket


Fulgent Genetics Inc.  (FLGT)
Other Ticker:  
 


 

Fulgent Genetics Inc.

FLGT's Financial Statements and Analysis



Fulgent Genetics Inc. reported in II. Quarter net earnings per share of $0.37 a decrease by -85.71 % year on year from $2.59 and decline of -92.49 % from $4.93 earned in I. Quarter (Mar 31 2022).


II. Quarter
Earnings Per Share Revenues
$ 0.37 $  125 Mill
$-2.22     -85.71 % $-28M     -18.41 %



Fulgent Genetics's Revenue fell by -18.41 % in II. Quarter (Jun 30 2022) year on year, to $125 million and declined by -60.86 % sequentially.


Fulgent Genetics is Expected to report next financial results on November 08, 2022.

More on FLGT's Income Statement



Fulgent Genetics's net income of $11.099 million in II. Quarter decreased by -86.06 % from net earnings of $79.647 million achieved in II. Quarter a year ago.

Sequentially net earnings fell by -92.77 % from net income of $153.557 million realized in previous quarter.

More on FLGT's Growth

In II. Quarter company's net cash and cash equivalents decreased by $-214 million, capital expenditures fell by 11.01%, to $-3 millions compare to same quarter a year ago and rose by -39.22% from I. Quarter (Mar 31 2022).

More on FLGT's Cash flow Statement


Fulgent Genetics Inc. does not pay out common stock dividend.

In trailing twelve-month period Fulgent Genetics Inc. earned $ 13.75 cash per share, on a free-cash flow basis 109.29 % of net earning per share.

Book value fell by -0.01 % sequentially to $42.03 per share.
Tangible Book value fell to $ 35.26 per share from $ 39.27.

Company repurchased 0.05 million shares or 0.16 % in II. Quarter.
Debt Coverage Ratio was 87.58.

More on FLGT's Dividends

 Market Capitalization (Millions) 1,189
 Shares Outstanding (Millions) 31
 Total Debt (Millions $) 6
 Revenue (TTM) (Millions $) 925
 Net Income (TTM) (Millions $) 391
 Cash Flow (TTM) (Millions $) 38
 Capital Exp. (TTM) (Millions $) -18
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Fulgent Genetics Inc. does not pay out common stock dividend.

In trailing twelve-month period Fulgent Genetics Inc. earned $ 13.75 cash per share, on a free-cash flow basis 109.29 % of net earning per share.

Book value fell by -0.01 % sequentially to $42.03 per share.
Tangible Book value fell to $ 35.26 per share from $ 39.27.

Company repurchased 0.05 million shares or 0.16 % in II. Quarter.
Debt Coverage Ratio was 87.58.

More on FLGT's Balance Sheets

 Market Capitalization (Millions) 1,189
 Shares Outstanding (Millions) 31
 Total Debt (Millions $) 6
 Revenue (TTM) (Millions $) 925
 Net Income (TTM) (Millions $) 391
 Cash Flow (TTM) (Millions $) 38
 Capital Exp. (TTM) (Millions $) -18
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

APHD's Profile

Stock Price

APHD's Financials

Business Description

Fundamentals

Charts & Quotes

APHD's News

Suppliers

APHD's Competitors

Customers & Markets

Economic Indicators

APHD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071